WO1999004003A1 - Procede d'obtention de plantes transgeniques dont la floraison est inhibee, et sequences d'adn utilisees dans ledit procede - Google Patents
Procede d'obtention de plantes transgeniques dont la floraison est inhibee, et sequences d'adn utilisees dans ledit procede Download PDFInfo
- Publication number
- WO1999004003A1 WO1999004003A1 PCT/NL1997/000424 NL9700424W WO9904003A1 WO 1999004003 A1 WO1999004003 A1 WO 1999004003A1 NL 9700424 W NL9700424 W NL 9700424W WO 9904003 A1 WO9904003 A1 WO 9904003A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- dna
- plants
- inhibited
- flowering
- Prior art date
Links
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 42
- 230000008569 process Effects 0.000 title claims abstract description 32
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 30
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 124
- 230000014509 gene expression Effects 0.000 claims abstract description 40
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 34
- 239000002299 complementary DNA Substances 0.000 claims abstract description 22
- 239000002773 nucleotide Substances 0.000 claims abstract description 15
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 15
- 230000005764 inhibitory process Effects 0.000 claims abstract description 13
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 7
- 230000002779 inactivation Effects 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 108020004414 DNA Proteins 0.000 claims description 36
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 13
- 102000053602 DNA Human genes 0.000 claims description 9
- 101150045515 O gene Proteins 0.000 claims description 9
- 230000000692 anti-sense effect Effects 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 9
- 108020005544 Antisense RNA Proteins 0.000 claims description 7
- 239000003184 complementary RNA Substances 0.000 claims description 7
- 230000035772 mutation Effects 0.000 claims description 7
- 230000032361 posttranscriptional gene silencing Effects 0.000 claims description 7
- 239000000470 constituent Substances 0.000 claims description 6
- 230000001747 exhibiting effect Effects 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 230000008488 polyadenylation Effects 0.000 claims description 6
- 230000005030 transcription termination Effects 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 108020004511 Recombinant DNA Proteins 0.000 claims description 3
- 238000012217 deletion Methods 0.000 claims description 3
- 230000037430 deletion Effects 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims description 3
- 108091033380 Coding strand Proteins 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 102000035118 modified proteins Human genes 0.000 claims description 2
- 108091005573 modified proteins Proteins 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 abstract description 84
- 240000007377 Petunia x hybrida Species 0.000 abstract description 21
- 210000000056 organ Anatomy 0.000 description 11
- 239000013598 vector Substances 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000006698 induction Effects 0.000 description 8
- 241000219194 Arabidopsis Species 0.000 description 7
- 239000000523 sample Substances 0.000 description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- 244000061456 Solanum tuberosum Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 238000000636 Northern blotting Methods 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 108010050848 glycylleucine Proteins 0.000 description 4
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 3
- 108700005087 Homeobox Genes Proteins 0.000 description 3
- 241000218922 Magnoliophyta Species 0.000 description 3
- 241000209504 Poaceae Species 0.000 description 3
- 235000021536 Sugar beet Nutrition 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 230000004883 flower formation Effects 0.000 description 3
- 108010025306 histidylleucine Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 241000207875 Antirrhinum Species 0.000 description 2
- JSLGXODUIAFWCF-WDSKDSINSA-N Arg-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O JSLGXODUIAFWCF-WDSKDSINSA-N 0.000 description 2
- VENMDXUVHSKEIN-GUBZILKMSA-N Arg-Ser-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VENMDXUVHSKEIN-GUBZILKMSA-N 0.000 description 2
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 2
- AYZAWXAPBAYCHO-CIUDSAMLSA-N Asn-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N AYZAWXAPBAYCHO-CIUDSAMLSA-N 0.000 description 2
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 2
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 2
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 2
- 102000006732 Citrate synthase Human genes 0.000 description 2
- VNLYIYOYUNGURO-ZLUOBGJFSA-N Cys-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N VNLYIYOYUNGURO-ZLUOBGJFSA-N 0.000 description 2
- 108700001191 DEFICIENS Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 102100030892 Fructose-1,6-bisphosphatase isozyme 2 Human genes 0.000 description 2
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 2
- HQTDNEZTGZUWSY-XVKPBYJWSA-N Glu-Val-Gly Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(O)=O HQTDNEZTGZUWSY-XVKPBYJWSA-N 0.000 description 2
- SOYWRINXUSUWEQ-DLOVCJGASA-N Glu-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O SOYWRINXUSUWEQ-DLOVCJGASA-N 0.000 description 2
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 2
- VHOLZZKNEBBHTH-YUMQZZPRSA-N His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 VHOLZZKNEBBHTH-YUMQZZPRSA-N 0.000 description 2
- 101000930766 Homo sapiens Far upstream element-binding protein 2 Proteins 0.000 description 2
- 101001063910 Homo sapiens Fructose-1,6-bisphosphatase isozyme 2 Proteins 0.000 description 2
- FJUKMPUELVROGK-IHRRRGAJSA-N Leu-Arg-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N FJUKMPUELVROGK-IHRRRGAJSA-N 0.000 description 2
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 2
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 2
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 2
- POMXSEDNUXYPGK-IHRRRGAJSA-N Leu-Met-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N POMXSEDNUXYPGK-IHRRRGAJSA-N 0.000 description 2
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 2
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 2
- NYTDJEZBAAFLLG-IHRRRGAJSA-N Lys-Val-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O NYTDJEZBAAFLLG-IHRRRGAJSA-N 0.000 description 2
- FYRUJIJAUPHUNB-IUCAKERBSA-N Met-Gly-Arg Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N FYRUJIJAUPHUNB-IUCAKERBSA-N 0.000 description 2
- BEZJTLKUMFMITF-AVGNSLFASA-N Met-Lys-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCNC(N)=N BEZJTLKUMFMITF-AVGNSLFASA-N 0.000 description 2
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- DBALDZKOTNSBFM-FXQIFTODSA-N Pro-Ala-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DBALDZKOTNSBFM-FXQIFTODSA-N 0.000 description 2
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 2
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 2
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 2
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 2
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 2
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 2
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 2
- 101100108341 Solanum lycopersicum TDR4 gene Proteins 0.000 description 2
- SIEZEMFJLYRUMK-YTWAJWBKSA-N Thr-Met-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N)O SIEZEMFJLYRUMK-YTWAJWBKSA-N 0.000 description 2
- PWIQCLSQVQBOQV-AAEUAGOBSA-N Trp-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 PWIQCLSQVQBOQV-AAEUAGOBSA-N 0.000 description 2
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 2
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 108091007916 Zinc finger transcription factors Proteins 0.000 description 2
- 102000038627 Zinc finger transcription factors Human genes 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 108010070783 alanyltyrosine Proteins 0.000 description 2
- 108010068380 arginylarginine Proteins 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 108010054155 lysyllysine Proteins 0.000 description 2
- 108010084572 phenylalanyl-valine Proteins 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108010077112 prolyl-proline Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 1
- GRPHQEMIFDPKOE-HGNGGELXSA-N Ala-His-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GRPHQEMIFDPKOE-HGNGGELXSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- YNOCMHZSWJMGBB-GCJQMDKQSA-N Ala-Thr-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YNOCMHZSWJMGBB-GCJQMDKQSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 108700007114 Arabidopsis AGAMOUS Proteins 0.000 description 1
- 108700040922 Arabidopsis LFY Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- BNODVYXZAAXSHW-IUCAKERBSA-N Arg-His Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 BNODVYXZAAXSHW-IUCAKERBSA-N 0.000 description 1
- ITHMWNNUDPJJER-ULQDDVLXSA-N Arg-His-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ITHMWNNUDPJJER-ULQDDVLXSA-N 0.000 description 1
- NPDLYUOYAGBHFB-WDSKDSINSA-N Asn-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NPDLYUOYAGBHFB-WDSKDSINSA-N 0.000 description 1
- HXWUJJADFMXNKA-BQBZGAKWSA-N Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O HXWUJJADFMXNKA-BQBZGAKWSA-N 0.000 description 1
- HDHZCEDPLTVHFZ-GUBZILKMSA-N Asn-Leu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O HDHZCEDPLTVHFZ-GUBZILKMSA-N 0.000 description 1
- ICZWAZVKLACMKR-CIUDSAMLSA-N Asp-His-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CN=CN1 ICZWAZVKLACMKR-CIUDSAMLSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- FIAKNCXQFFKSSI-ZLUOBGJFSA-N Asp-Ser-Cys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O FIAKNCXQFFKSSI-ZLUOBGJFSA-N 0.000 description 1
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 102100037181 Fructose-1,6-bisphosphatase 1 Human genes 0.000 description 1
- MPZWMIIOPAPAKE-BQBZGAKWSA-N Glu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N MPZWMIIOPAPAKE-BQBZGAKWSA-N 0.000 description 1
- CGYDXNKRIMJMLV-GUBZILKMSA-N Glu-Arg-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CGYDXNKRIMJMLV-GUBZILKMSA-N 0.000 description 1
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 1
- AIGROOHQXCACHL-WDSKDSINSA-N Glu-Gly-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O AIGROOHQXCACHL-WDSKDSINSA-N 0.000 description 1
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- IMRNSEPSPFQNHF-STQMWFEESA-N Gly-Ser-Trp Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O IMRNSEPSPFQNHF-STQMWFEESA-N 0.000 description 1
- 101001028852 Homo sapiens Fructose-1,6-bisphosphatase 1 Proteins 0.000 description 1
- 241001293495 Lactuca virosa Species 0.000 description 1
- NFNVDJGXRFEYTK-YUMQZZPRSA-N Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O NFNVDJGXRFEYTK-YUMQZZPRSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- IWTBYNQNAPECCS-AVGNSLFASA-N Leu-Glu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IWTBYNQNAPECCS-AVGNSLFASA-N 0.000 description 1
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 1
- AIRUUHAOKGVJAD-JYJNAYRXSA-N Leu-Phe-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIRUUHAOKGVJAD-JYJNAYRXSA-N 0.000 description 1
- VKVDRTGWLVZJOM-DCAQKATOSA-N Leu-Val-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O VKVDRTGWLVZJOM-DCAQKATOSA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- RVOMPSJXSRPFJT-DCAQKATOSA-N Lys-Ala-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVOMPSJXSRPFJT-DCAQKATOSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 1
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 1
- YCUSPBPZVJDMII-YUMQZZPRSA-N Met-Gly-Glu Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O YCUSPBPZVJDMII-YUMQZZPRSA-N 0.000 description 1
- YYEIFXZOBZVDPH-DCAQKATOSA-N Met-Lys-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O YYEIFXZOBZVDPH-DCAQKATOSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- UAMFZRNCIFFMLE-FHWLQOOXSA-N Phe-Glu-Tyr Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N UAMFZRNCIFFMLE-FHWLQOOXSA-N 0.000 description 1
- IAOZOFPONWDXNT-IXOXFDKPSA-N Phe-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IAOZOFPONWDXNT-IXOXFDKPSA-N 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- STASJMBVVHNWCG-IHRRRGAJSA-N Pro-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 STASJMBVVHNWCG-IHRRRGAJSA-N 0.000 description 1
- OFSZYRZOUMNCCU-BZSNNMDCSA-N Pro-Trp-Met Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(O)=O)C(=O)[C@@H]1CCCN1 OFSZYRZOUMNCCU-BZSNNMDCSA-N 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- UCOYFSCEIWQYNL-FXQIFTODSA-N Ser-Cys-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(O)=O UCOYFSCEIWQYNL-FXQIFTODSA-N 0.000 description 1
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 1
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 1
- IFLVBVIYADZIQO-DCAQKATOSA-N Ser-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N IFLVBVIYADZIQO-DCAQKATOSA-N 0.000 description 1
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 1
- QPPYAWVLAVXISR-DCAQKATOSA-N Ser-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QPPYAWVLAVXISR-DCAQKATOSA-N 0.000 description 1
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 1
- AXKJPUBALUNJEO-UBHSHLNASA-N Ser-Trp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O AXKJPUBALUNJEO-UBHSHLNASA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 241001406921 Squamosa Species 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- NOWXWJLVGTVJKM-PBCZWWQYSA-N Thr-Asp-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O NOWXWJLVGTVJKM-PBCZWWQYSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- NOXKHHXSHQFSGJ-FQPOAREZSA-N Tyr-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NOXKHHXSHQFSGJ-FQPOAREZSA-N 0.000 description 1
- XQYHLZNPOTXRMQ-KKUMJFAQSA-N Tyr-Glu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XQYHLZNPOTXRMQ-KKUMJFAQSA-N 0.000 description 1
- UBKKNELWDCBNCF-STQMWFEESA-N Tyr-Met-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UBKKNELWDCBNCF-STQMWFEESA-N 0.000 description 1
- MDXLPNRXCFOBTL-BZSNNMDCSA-N Tyr-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MDXLPNRXCFOBTL-BZSNNMDCSA-N 0.000 description 1
- VVZDBPBZHLQPPB-XVKPBYJWSA-N Val-Glu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VVZDBPBZHLQPPB-XVKPBYJWSA-N 0.000 description 1
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 101150025475 agl8 gene Proteins 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 230000005014 ectopic expression Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000032367 vegetative phase change Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
- C12N15/827—Flower development or morphology, e.g. flowering promoting factor [FPF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Definitions
- the present invention is related to recombinant DNA, particularly to recombinant DNA in relation to genetic modification of plants.
- the modification relates to altering the flowering process of plants and specifically to inhibiting flowering in genetically engineered plants.
- the present invention also relates to DNA sequences which code for MADS box transcription factors, which, upon integration into a plant genome, modify flowering.
- Plant development is characterised by a series of phase changes in which meristems are capable of generating new meristems of different identity.
- Vegetative meristems produce roots and leaves and may give rise to generative meristems upon floral induction (evocation) .
- floral induction evocation
- the switch from vegetative to generative phase is induced in response to many environmental conditions such as temperature, light conditions, and day-length.
- the process of flower induction is influenced by internal factors such as the age of the plant, hormones and gene products (Bernier, 1988) . Almost nothing is known, however, about the molecular and genetic controls that induce a plant to flower.
- the new flower meristems form flowers, whereas vegetative meristems produce leaves.
- the new flower meristems are formed in the axils of small leaf-like organs which are called bracts. These bracts are distinguishable from vegetative leaves with respect to their shape and position in the plant.
- the next developmental step is the determination of the identity of the floral organs, sepals, petals, stamens and carpels, which develop as distinct primordia from the floral apex. In the stamens and carpels, the reproductive cells are produced and upon fertilisation seeds are formed giving rise to the next generation. Mutants affected in the flowering process have been characterised from many species, in particular, from Arabidopsis thaliana .
- a number of Arabidopsis mutants are known displaying an early or late flowering phenotype (see for review, eigel, 1995) . Although the transition from vegetative to reproductive phase can be delayed dramatically in some of these late flowering mutants, eventually they start to flower, indicating that the affected genes are not essential for flowering. Many of these early- and late- flowering genes are thought to modify the transduction of the external factors which are involved in flower induction.
- the late- flowering gene CONSTANS (CO) which encodes a Zinc finger transcription factor (Putterill et al, 1995 ) is involved in light perception or transduction and, upon mutation, results in a late flowering phenotype specifically under short-day conditions.
- Another Arabidopsis gene that affects flowering time and have been cloned is LUMINIDEPENDENS (Lee et al . , 1994) .
- ID INDETERMINATE
- This ID gene encodes a Zinc finger transcription factor and disturbance of this gene by insertion of a DS transposable element resulted in the inhibition of flowering in maize plants.
- the so-called 'meristem identity' genes that control the identity of the flower meristem can also be used. These genes are LEAFY (LFY, Weigel et al . , 1992 and APETALA1 (API , Mandel et al., 1992J from Arabidopsis and their ho ologues from Antirrhinum FLORICAULA (FLO, Coen et al., 1990) and SQUAMOSA (SQUA, Huijser et al . , 1992), respectively.
- LEAFY LEAFY, Weigel et al . , 1992
- API Mandel et al., 1992J from Arabidopsis and their ho ologues from Antirrhinum FLORICAULA (FLO, Coen et al., 1990)
- SQUAMOSA SQUA, Huijser et al . , 1992
- API and SQUA are both members of the MADS box gene family coding for transcription factors. These MADS box transcription factors share a highly conserved domain which is called the 'MADS box' and facilitates the DNA binding (Schwarz-Sommer et al., 1990) .
- the identity of the floral organs, sepals, petals, stamens, carpels, and within the carpels, the ovules is determined by four classes of homeotic genes. These homeotic genes are acting alone or in combination to determine floral organ identity. A model describing the action of these genes has been proposed first by Coen and Meyerowitz (1991) and later modified for genes controlling ovule identity by Colombo et al. (1995). Most of these organ identity genes belong to the MADS box gene family. The function of these genes has been determined in a number of dicotyledon and monocotyledon species by gene inactivation and ectopic expression in transgenic plants. These studies have demonstrated that these homeotic genes are well conserved in the plant kingdom and play similar roles with respect to flower development in many species.
- the reproductive phase is characterised by the production of flowers which is often preceded by the formation of an inflorescence.
- Inflorescence An inflorescence is characterised by a structure bearing the flowers which arises from the axils of leaf-like organs called 'bracts'.
- Antisense construct or gene a gene or a nucleotide sequence derived thereof, having a homology of more than 70%, preferably more than 90% to a target gene and which is linked to a promoter in the inverse 3 ' to 5 ' orientation with respect to the target gene.
- Cosuppression construct or gene a gene or a nucleotide sequence derived thereof, having a homology of more than 70%, preferably more than 90% to the target gene and which is linked to a promoter in the 5' to 3 ' orientation or which expression is not driven by an exogenous promoter.
- MADS box gene a gene coding for a transcription factor having a region of 56 a ino acids which is homologous to a similar region in the Arabidopsis AGAMOUS protein and Antirrhinum DEFICIENS protein. This region is called the 'MADS box' . At least 50% of the amino acids in this region should be identical to the amino acid composition in the MADS boxes of AGAMOUS and DEFICIENS.
- Inhibiting flower formation can be advantageous in plants which multiply in predominantly vegetative manner. Flowers are strong sink tissues and therefore, prevention of flowering may lead to an increased deposition of stored substances in storage organs and increased growth of vegetative organs such as leaves, stems and roots. It therefore appears desirable to provide a method to inhibit flowering independent from external factors and without exogenous application of substances .
- the present invention provides a method to produce genetically engineered plants in which the flowering process is altered. More specifically, the inventors have found a method for reducing flowering or completely abolishing the formation of inflorescences and flowers.
- inhibiting flowering means that the transformed plants do not produce inflorescences, neither inflorescences bearing flowers nor inflorescences without flowers, develop fewer inflorescences or short inflorescences with a single or a few flowers.
- this invention provides an isolated DNA sequence which encodes a MADS box protein indicated FBP10 and having the amino acid sequence given in SEQ ID NO:2 of the sequence listing hereinafter or a functionally homologous protein or part thereof, wherein inactivation of gene function of said DNA sequence, if present as an endogenous gene in a plant, results in inhibition of flowering.
- the DNA sequence of the invention can also be characterized in that it comprises the FBP10 gene or corresponding cDNA having the nucleotide sequence given in SEQ ID N0:1 or a functionally homologous gene or an essentially identical nucleotide sequence or part thereof or derivatives thereof which are derived from said sequence by insertion, deletion or substitution of one or more nucleotides.
- the invention provides an RNA sequence encoded by any of the above defined DNA sequences .
- the invention provides a protein encoded by any of the above defined DNA sequences . Further the invention provides processes of producing transgenic plants in which flowering is inhibited, comprising inhibiting the expression of endogenous FBP10 gene or a homologous gene.
- the invention provides recombinant double- stranded DNA molecules comprising an expression cassette to be used in the above process .
- the invention provides transgenic plants showing inhibited flowering, and also plant cells, seeds, tissue culture, plant parts or progeny plants derived from said transgenic plants.
- Figure 1 is the cDNA sequence of the petunia FBP10 gene and the deduced amino acid sequence.
- the MADS box region is underlined.
- Figure 2 is a comparison of the petunia FBP10 protein sequence and known homologous protein sequences from potato (P0TM1) , tomato (TDR4) , and Arabidopsis (AGL8) .
- P0TM1 petunia FBP10 protein sequence
- TDR4 tomato
- AGL8 Arabidopsis
- Figure 3 shows the expression of FBP10 in wild type petunia plants (line W115) and in FBP10 plants as determined by Northern blot analysis.
- the blot contains total RNA from the tissues as indicated: leaf, stem, bract, sepal, petal, stamen, style/stigma, ovary and leaf, stem, shoot and flower from the cosuppression plant.
- the Smal/Hindlll DNA fragment (nucleotide 325-885) of FBP10 cDNA was used as probe.
- Figure 4 shows the expression of FBP10 by in si tu hybridisations using a digoxygenin labeled antisense RNA probe ( Figures 4B, 4D, and 4F) derived from the Smal/Hindlll fragment (nucleotide 325-885) of FBP10 cDNA.
- Sense control probe has been used for figures 4A, 4C, and 4E.
- Figures A and B show longitudinal sections through an apical meristem, C and D show an axillary vegetative meristem and in E and F floral buds are depicted.
- a apical mersitem
- am axillary meristem
- l leaf
- b bract
- f floral meristem
- l sepal
- 2 petal
- 3 stamen.
- Figure 5 depicts a schematic presentation of the T-DNA region between the borders of the binary vector containing the FBPIO sense construct.
- This binary vector designated pFBP113, was used to generate transgenic petunia plants in which FBPI O expression was inhibited.
- Figure 6 shows the phenotype of a wild type petunia plant (a left) and representative plants in which the expression of FBPI O was inhibited (a right and b) .
- the DNA sequence of the invention encodes a MADS box protein indicated FBPIO or a fucntionally homologous protein or part thereof.
- the cDNA sequence of the FBP10 gene and the deduced amino acid sequence are given in Fig. 1 and in SEQ ID No:l and 2.
- the term "functionally homologous" in the present description and claims should be understood to mean proteins and genes belonging to the MADS box family and being functionally equivalent to FBP10 protein and FBP10 gene, respectively. Inhibition of the endogenous FBP10 gene in a plant results in inhibition of flowering.
- Homologous sequences are, for example, sequences derived from other organisms than petunia. The percentage of sequence similarity of FBP10 and a homologous gene may vary.
- the functionally homologous gene from a species related to petunia may have more than 90% sequence identity, whereas the functional homologue from a non-related species may have only 65% or less sequence identity.
- the invention also relates to derivatives of the FBP10 gene or a homologous gene, which can be derived from the parent sequence by insertion, deletion or substitution of one or more nucleotides. This includes naturally occurring variations or variations introduced through targeted mutagenesis or recombination.
- the expression of endogenous FBPI O gene or a homologous gene is inhibited by the use of anti-sense RNA.
- the process comprises the following steps: a) a DNA, or a DNA fragment having at least 15 base pairs, which is complementary to a degree of at least 70% to the FBP10 gene or homologous gene is introduced in a plant cell, b) said introduced DNA is transcribed into anti- sense RNA, said DNA being expressed constitutively or tissue- specific, or being induced by promoter elements controlling the expression of the introduced DNA, c) the expression of endogenous FBP10 gene or homologous gene is inhibited because of the anti-sense effect, d) plants are regenerated from the transgenic cells, and e) plants exhibiting inhibited flowering are selected.
- step a) instead of the complete FBP10 gene or homologus gene sequence, partial sequences thereof can be used to obtain antisense inhibition. Sequences up to a minimum length of 15 base pairs can be used. It is also possible to use DNA sequences which have a high degree of similarity to the FBP10 gene or homologous gene sequence. The minimum similarity should be 70%, preferably more than 90%.
- the expression of endogenous FBP10 or a homologous gene is inhibited through the use of sense/cosuppression.
- the process comprises the following steps: a) a DNA which is the FBP10 gene or homologous gene or a sequence having at least 70% sequence similarity to said
- FBP10 or homologous gene, or a fragment thereof having at least 15 base pairs is introduced in a plant cell, b) said DNA being expressed constitutively or tissue- specific or being induced by promoter elements controlling the expression of the introduced DNA in such a way that transcription produces sense RNA, or being introduced without the use of a promoter, c) the expression of endogenous FBPI O gene or homologous gene and the introduced gene are inhibited by the cosuppression effect, d) plants are regenerated from the transgenic cells, and e) plants exhibiting inhibited flowering are selected.
- partial sequences of at least 15 base pairs, and sequences having a similarity of at least 70%, preferably at least 90%, can be used.
- the expression of endogenous FBP10 or a homologous gene is inhibited by the use of dominant- negative mutations.
- the process comprises the following steps: a) a DNA which encodes a modified FBP10 protein or homologous protein or an essential part thereof, whereby said modified protein or part thereof is suitable for inhibiting the function of the endogenous FBP10 protein or homologous protein, is introduced in a plant cell, b) said introduced DNA is transcribed into RNA and translated into a polypeptide, said DNA being expressed constitutively or tissue- specific, or being induced by promoter elements controlling the expression of the introduced DNA, c) the function of the endogenous FBP10 protein or homologous protein is inhibited by the dominant-negative mutation effect, d) plants are regenerated from the transgenic cells, and e) plants exhibiting inhibited flowering are selected.
- the transgenic plants produced by this process express an altered FBP10 protein or homologue thereof. As a result said plants are changed in their flowering behaviour.
- This strategy has been successful for the inhibition of the Arabidopsis MADS box protein AGAMOUS by expressing a c-terminal truncated AGAMOUS protein (Ma et al, 1996) .
- the invention also relates to recombinant double-stranded DNA molecules for use in the above processes for producing transgenic plants.
- the invention provides a recombinant double-stranded DNA molecule for use in the anti-sense method, comprising an expression cassette comprising the following constituents: i) a promoter functional in plants, ii) a DNA sequence which is FBP10 gene or a homologous gene as defined above, which is fused to the promoter in anti-sense orientation so that the non- coding strand is transcribed, and if necessary iii) a signal fucntional in plants for the transcription termination and polyadenylation of an RNA molecule.
- the invention provides a recombinant double-stranded DNA molecule for use in the sense/cosuppression method, comprising an expression cassette comprising the following constituents: i) a DNA sequence which is FBP10 gene or a homologous gene as defined above, ii) optionally a promoter functional in plants, which is fused to the DNA sequence in sense orientation, and if necessary iii) a signal functional in plants for the transcription termination and polyadenylation of an RNA molecule.
- the invention provides a recombinant double-stranded DNA-molecule for use in the dominant-negative mutation method, comprising an expression cassette comprising the following constituents: i) a promoter functional in plants, ii) a DNA sequence which is a modified FBP10 gene or homologous gene as defined above, which is fused to the promoter in sense orientation, and if necessary iii) a signal functional in plants for the transcription termination and polyadenylation of an RNA molecule.
- a preferred promoter to be used in any of the above processes or recombinant double-stranded DNA molecules for expressing the said recombinant polynucleotide that is active in the shoot apical meristems comprises the cauliflower mosaic virus (CaMV) 35S promoter.
- the promoter is an inducible promoter active in the shoot meristem or a tissue-specific promoter active in the shoot meristem.
- an inducible promoter which can be activated or suppressed in response to external stimuli. Activation or suppression of the promoter results in plants displaying characteristics according to the present invention.
- the present invention provides plants without inflorescences or flowers. Because flowers and seeds and fruits produced thereof are high energy demanding tissues
- the present invention provides a method to increase the total biomass of vegetative tissues, such as roots, tubers, stems and leaves.
- the present invention can be used in Gymnosperms and
- Angiosperms The present invention is especially useful for plant species for which vegetative propagation is possible.
- parent plants carrying transgenes related to the DNA sequence shown in figure 1 (SEQ ID NO: 1
- the parent plants have a wild-type phenotype.
- the present invention is especially useful for plant species for which the vegetative part of the plant is used as the economical product such as vegetables (e.g. lettuce, spinach, chicory, etc.), sugar beet, potato, trees for wood production (e.g. Eucalyptus, oak, willow, etc), tobacco, grasses, plants for nitrogen fixation, ornamental plants for production of cuttings.
- vegetables e.g. lettuce, spinach, chicory, etc.
- sugar beet e.g.
- trees for wood production e.g. Eucalyptus, oak, willow, etc
- tobacco, grasses e.g. Eucalyptus, oak, willow, etc
- ornamental plants for production of cuttings e.g. Eucalyptus, oak, willow, etc
- the use of the present invention is of particular interest to sugar beet, since "bolting" can be prevented by inhibition of inflorescence formation.
- This flower induction process is induced by vernalization (cold treatment) and can be circumvented by planting relatively late in the year (April/May) . Inhibition of inflorescence formation by applying the present invention will allow an earlier planting of the sugar beet resulting in an increase in yield.
- the use of the present invention is of particular interest for grasses to improve its quality as feed for cattle. Inflorescences of grasses contain relatively low quantities of carbohydrates and large quantitives of lignin, which cannot be digested by cattle.
- Petunia MADS box cDNA clones were isolated from a cDNA library made from young petunia pistils (Angenent et al . , 1993)
- the cDNA library was constructed using the lambda ZAP cloning vector (Stratagene)
- the library was screened under low stringency hybridization conditions with a mixed probe comprising the MADS box regions of Floral binding protein gene 1 ⁇ FBP1 ) and FBP2 (Angenent et al . , 1993).
- the hybridizing phage plaques were further purified using standard techniques. Using the in vivo excision method, E.
- coli clones which contain a double-stranded Bluescript SK-plasmid with the cDNA insertion between the EcoRl and Xhol cleavage site of the polylinker were generated.
- Cross-hybridization of the purified clones revealed 10 independent clones designated FBP2, FBP6- 14.
- FBP10 The nucleotide sequence of a full length clone (clone CIO) was determined by the dideoxynucleotide-mediated chain termination method and is depicted in Figure 1 (SEQ ID NO:l).
- the FBPI O cDNA clone has a length of 1131 nucleotides and encodes for a polypeptide of 246 amino acid residues.
- FBPIO a N-terminal located MADS box region which shows a high degree of similarity with other MADS box proteins, and a K-box in the middle of the protein with an alpha helical structure.
- the alignment of FBPIO and homologues from Arabidopsis, potato and tobacco is shown in Figure 2.
- FBPIO is most similar to the potato MADS box protein POTM1 (Kang and Hannapel, 1995) .
- the functions of POTM1, TDR4, and AG18 have not been determined yet.
- FBPI O The expression of FBPI O was determined by standard Northern blot hybridization experiments according to Angenent et al. (1992). A Smal/Hindll DNA fragment containing nucleotides 325 to 885 of FBPIO cDNA was used as a probe. Using 10 ⁇ g of total RNA from various petunia tissues, expression of FBP10 was detectable in young leaves, stems, bracts, and all floral organs except anthers. No expression was detectable in roots and old leaves ( Figure 3) . The expression in the apical meristem was determined by in situ hybridization using a DIG labeled antisense RNA probe corresponding to the Smal/Hindlll fragment of the FBP10 cDNA. ( Figure 4) .
- RNA transcripts were made using T7 RNA polymerase.
- a standard protocol for in situ hybridization was used as described by Canas et al . , 1994. Strong hybridizing signals were observed in the vegetative apical meristem, floral meristem and weaker signals in the developing leaves .
- the full length FBP10 cDNA was subcloned into the binary vector pFBP20 (Angenent et al . , 1993).
- This binary vector contains the CaMV 35S promoter, the adh intron, a multiple cloning site for insertion of the cDNA and the nos terminator.
- the full length cDNA clone (CIO) present in the bluescript SK- vector (Strategene lambda ZAP excision vector) was cut with BamHl and Xhol and reinserted in the binary vector pFBP20 yielding plasmid pFBP113 ( Figure 5) .
- the binary vector containing the FBPI O cDNA in the sense orientation behind the CaMV 35S promoter was transferred to Agrobacterium tumefaciens strain LBA4404 by triparental mating.
- the plasmid was transferred from E.coli HB101 to LBA4404 using a strain containing plasmid pRK2013.
- Plasmid DNA from the Agrobacterium conjugates were isolated and the structure of the binary vector was verified by restriction analysis.
- Agrobacterium conjugants were used to transform Petunia hybrida leaf disks as described by Horsch et al. (1985) .
- Leaf disks were prepared from top leaves of young Petunia hybrida variety W115 plants. After shoot and root induction on Kanamycin selection media, plants were planted in soil and transferred to the greenhouse.
- Wild-type petunia plants have indetermined inflorescences of the raceme type ( Figure 6a) .
- Figure 6a In the axils of two bracts, which are positioned opposite to each other, a flower is formed and the inflorescence continues. Under normal greenhouse conditions, this inflorescence maintains an inflorescence identity and never reverses to the vegetative phase. Vegetative leaves are not positioned opposite to each other like bracts, but are arranged in a spiral phylotaxy. Two plants were selected which showed abberations in inflorescence structure. Occasionally, part of these inflorescences reverted to short vegetative shoots.
- T30.009 and T30.012 were self pollinated and the offspring were analyzed.
- the offspring of T30.009 could be divided into three classes: 8 plants with a wild-type phenotype, 12 plants with a phenotype resembling the primary transformant, and 5 plants with severe alterations in inflorescence development. Plants from the latter class are affected in the switch from vegetative to inflorescence phase, in that vegetative shoots are produced instead of indetermined inflorescences ( Figures 6a and 6b) .
- Vernalization is a well known inducer of flowering for many species. Therefore, we analysed the stability of the non- flowering phenotype of the FBP10 mutant by exposure of the plants to cold conditions (4 °C) for 4 and 8 weeks. Wild type plants (line W115) were treated simultaneously. The plants (4 plants of each) were transferred to the cold about two weeks before they start to flower under normal greenhouse conditions (20 °C) . The cold treatments did not affect the timing of flowering, neither for the wild type plants nor for the FBPIO mutants. About two weeks after the treatment wild type plants started to flower, while the FBPIO mutants remained vegetative just like the untreated FBPIO mutant plants.
- Floricaula a homeotic gene required for flower development in Antirrhinum majus. Cell, 63, 1311-1322.
- Bracteomania an inflorescence anomaly, is caused by the loss of function of the MADS box gene sguamosa in Antirrhinum majus .
- MOLECULE TYPE cDNA to mRNA
- HYPOTHETICAL NO
- ANTI -SENSE NO
- AAAA ATG GGA AGA GGA AGA GTG CAG ATG AAG AGA ATT GAG AAT AAA ATT 109 Met Gly Arg Gly Arg Val Gin Met Lys Arg lie Glu Asn Lys lie 1 5 10 15
- GCA AAA CTT AAG GCC AGA ATT GAG GTT GTG CAG AGA AAC CAA AGG CAT 397 Ala Lys Leu Lys Ala Arg lie Glu Val Val Gin Arg Asn Gin Arg His 100 105 110
- GAG AAA GAG TTG GCT CAA CAA ACT CAA TGG GAG CAG CAG AAT AAT CAT 637 Glu Lys Glu Leu Ala Gin Gin Thr Gin Trp Glu Gin Gin Asn Asn His 180 185 190
- GATCTTATTT ACTGTATCAG CAGCCTTGCC TTGAATAACT TAAATATTCT GAATGATCT 1131
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physiology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL1997/000424 WO1999004003A1 (fr) | 1997-07-18 | 1997-07-18 | Procede d'obtention de plantes transgeniques dont la floraison est inhibee, et sequences d'adn utilisees dans ledit procede |
| EP97930888A EP0985041A1 (fr) | 1997-07-18 | 1997-07-18 | Procede d'obtention de plantes transgeniques dont la floraison est inhibee, et sequences d'adn utilisees dans ledit procede |
| IL13408397A IL134083A0 (en) | 1997-07-18 | 1997-07-18 | Process of producing transgenic plants in which flowering is inhibited, and dna sequences used in said process |
| PL97338241A PL338241A1 (en) | 1997-07-18 | 1997-07-18 | Method of obtaining transgenic plants of inhibited efflorescence |
| NZ502374A NZ502374A (en) | 1997-07-18 | 1997-07-18 | Production of transgenic plants in which flowering is inhibited by using the FBP10 gene |
| BR9714986-1A BR9714986A (pt) | 1997-07-18 | 1997-07-18 | Processo de produção de plantas transgênicasnas quais a floração é inibida e sequências de dnausadas no referido processo |
| AU34655/97A AU742459B2 (en) | 1997-07-18 | 1997-07-18 | Process of producing transgenic plants in which flowering is inhibited, and DNA sequences used in said process |
| CA002296761A CA2296761A1 (fr) | 1997-07-18 | 1997-07-18 | Procede d'obtention de plantes transgeniques dont la floraison est inhibee, et sequences d'adn utilisees dans ledit procede |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL1997/000424 WO1999004003A1 (fr) | 1997-07-18 | 1997-07-18 | Procede d'obtention de plantes transgeniques dont la floraison est inhibee, et sequences d'adn utilisees dans ledit procede |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999004003A1 true WO1999004003A1 (fr) | 1999-01-28 |
Family
ID=19866201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/NL1997/000424 WO1999004003A1 (fr) | 1997-07-18 | 1997-07-18 | Procede d'obtention de plantes transgeniques dont la floraison est inhibee, et sequences d'adn utilisees dans ledit procede |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0985041A1 (fr) |
| AU (1) | AU742459B2 (fr) |
| CA (1) | CA2296761A1 (fr) |
| IL (1) | IL134083A0 (fr) |
| WO (1) | WO1999004003A1 (fr) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000070053A1 (fr) * | 1999-05-18 | 2000-11-23 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Plantes transgeniques a temps de floraison modifie |
| WO2001004315A3 (fr) * | 1999-07-12 | 2001-07-12 | Texas A & M Univ Sys | Compositions de genes rin et leurs procedes d'utilisation |
| WO2002036776A1 (fr) * | 2000-10-30 | 2002-05-10 | National Institute Of Agrobiological Sciences | Amelioration apportee a un gene a mads box ciblant un type de fleur |
| EP1231835A4 (fr) * | 1999-10-12 | 2005-03-16 | Mendel Biotechnology Inc | Modification du temps de floraison |
| US8022274B2 (en) | 1998-09-22 | 2011-09-20 | Mendel Biotechnology, Inc. | Plant tolerance to low water, low nitrogen and cold |
| EP2272962B1 (fr) * | 2002-09-18 | 2017-01-18 | Mendel Biotechnology, Inc. | Polynucléotides et polypeptides dans les plantes |
| CN108949773A (zh) * | 2017-05-18 | 2018-12-07 | 萧郁芸 | 兰花胚珠发育调控基因及其方法 |
| US11124801B2 (en) | 2018-04-18 | 2021-09-21 | Pioneer Hi-Bred International, Inc. | Genes, constructs and maize event DP-202216-6 |
| US12371702B2 (en) | 2018-04-18 | 2025-07-29 | Pioneer Hi-Bred International, Inc. | Improving agronomic characteristics in maize by modification of endogenous mads box transcription factors |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995024487A1 (fr) * | 1994-03-09 | 1995-09-14 | Hoechst Schering Agrevo Gmbh | Procedes d'inhibition et de declenchement de la floraison des plantes |
| WO1996011566A1 (fr) * | 1994-10-14 | 1996-04-25 | Washington State University Research Foundation | Regulation genique du developpement floral et de la dominance apicale dans des plantes |
-
1997
- 1997-07-18 AU AU34655/97A patent/AU742459B2/en not_active Ceased
- 1997-07-18 CA CA002296761A patent/CA2296761A1/fr not_active Abandoned
- 1997-07-18 IL IL13408397A patent/IL134083A0/xx unknown
- 1997-07-18 EP EP97930888A patent/EP0985041A1/fr not_active Withdrawn
- 1997-07-18 WO PCT/NL1997/000424 patent/WO1999004003A1/fr not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995024487A1 (fr) * | 1994-03-09 | 1995-09-14 | Hoechst Schering Agrevo Gmbh | Procedes d'inhibition et de declenchement de la floraison des plantes |
| WO1996011566A1 (fr) * | 1994-10-14 | 1996-04-25 | Washington State University Research Foundation | Regulation genique du developpement floral et de la dominance apicale dans des plantes |
Non-Patent Citations (3)
| Title |
|---|
| ANGENENT G. ET AL.: "Co-suppression of the petunia homeotic gene fbp2 affects the identity of the generative meristem", THE PLANT JOURNAL, vol. 5, no. 1, 1994, pages 33 - 44, XP002058112 * |
| COLOMBO L. ET AL.: "Molecular control of flower development in Petunia hybrida", ADVANCES IN BOTANICAL RESEARCH INCORPORATING ADVANCES IN PLANT PATHOLOGY, vol. 26, June 1997 (1997-06-01), pages 229 - 250, XP002058585 * |
| KANG S. AND HANNAPEL D.: "A novel MADS-box gene of potato (Solanum tuberosum L.) expressed during the early stages of tuberization", PLANT MOLECULAR BIOLOGY, vol. 31, no. 2, May 1996 (1996-05-01), pages 379 - 386, XP002058584 * |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022274B2 (en) | 1998-09-22 | 2011-09-20 | Mendel Biotechnology, Inc. | Plant tolerance to low water, low nitrogen and cold |
| EP1055729A1 (fr) * | 1999-05-18 | 2000-11-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Plantes tansgeniques presentant un debut de floraison modifie |
| WO2000070053A1 (fr) * | 1999-05-18 | 2000-11-23 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Plantes transgeniques a temps de floraison modifie |
| WO2001004315A3 (fr) * | 1999-07-12 | 2001-07-12 | Texas A & M Univ Sys | Compositions de genes rin et leurs procedes d'utilisation |
| EP1231835A4 (fr) * | 1999-10-12 | 2005-03-16 | Mendel Biotechnology Inc | Modification du temps de floraison |
| WO2002036776A1 (fr) * | 2000-10-30 | 2002-05-10 | National Institute Of Agrobiological Sciences | Amelioration apportee a un gene a mads box ciblant un type de fleur |
| US7282622B2 (en) | 2000-10-30 | 2007-10-16 | National Institute Of Agrobiological Sciences | Flower morphology of plants by targeting mads-box gene |
| EP2272962B1 (fr) * | 2002-09-18 | 2017-01-18 | Mendel Biotechnology, Inc. | Polynucléotides et polypeptides dans les plantes |
| CN108949773A (zh) * | 2017-05-18 | 2018-12-07 | 萧郁芸 | 兰花胚珠发育调控基因及其方法 |
| CN108949773B (zh) * | 2017-05-18 | 2023-12-26 | 萧郁芸 | 产生转基因植物的方法 |
| US11124801B2 (en) | 2018-04-18 | 2021-09-21 | Pioneer Hi-Bred International, Inc. | Genes, constructs and maize event DP-202216-6 |
| US11421242B2 (en) | 2018-04-18 | 2022-08-23 | Pioneer Hi-Bred International, Inc. | Genes, constructs and maize event DP-202216-6 |
| US12234470B2 (en) | 2018-04-18 | 2025-02-25 | Pioneer Hi-Bred International, Inc. | Genes, constructs and maize event DP-202216-6 |
| US12371702B2 (en) | 2018-04-18 | 2025-07-29 | Pioneer Hi-Bred International, Inc. | Improving agronomic characteristics in maize by modification of endogenous mads box transcription factors |
Also Published As
| Publication number | Publication date |
|---|---|
| IL134083A0 (en) | 2001-04-30 |
| EP0985041A1 (fr) | 2000-03-15 |
| AU742459B2 (en) | 2002-01-03 |
| AU3465597A (en) | 1999-02-10 |
| CA2296761A1 (fr) | 1999-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6670526B1 (en) | Arabidopsis ESD4 gene and method to control flowering time | |
| US7157279B2 (en) | Flowering genes | |
| Tadege et al. | Control of flowering time by FLC orthologues in Brassica napus | |
| JP3898223B2 (ja) | 開花の遺伝的調節 | |
| US6887708B1 (en) | Plant control genes | |
| CA2363911C (fr) | Procedes de modification de la masse organique, de controle de la fertilite, et d'amelioration de la reproduction asexuee chez les plantes | |
| JPH10508481A (ja) | 開花の遺伝的制御 | |
| US7057087B2 (en) | Application of aspen MADS-box genes to alter reproduction and development in trees | |
| EP1204759A2 (fr) | Plantes modifiees | |
| Brill et al. | Ectopic expression of a Eucalyptus grandis SVP orthologue alters the flowering time of Arabidopsis thaliana | |
| AU742459B2 (en) | Process of producing transgenic plants in which flowering is inhibited, and DNA sequences used in said process | |
| AU725196B2 (en) | Seed plants exhibiting inducible early reproductive development and methods of making same | |
| US7595434B2 (en) | Methods for altering organ mass in plants | |
| AU7718298A (en) | Genes controlling floral development and apical dominance in plants | |
| AU734895B2 (en) | Gene for floral regulation and methods for controlling of flowering | |
| US5811536A (en) | Cauliflower floral meristem identity genes and methods of using same | |
| AU725704B2 (en) | Maize and cauliflower apetala1 gene products and nucleic acid molecules encoding same | |
| KR100832257B1 (ko) | 식물 디옥시하이푸신 신타제, 식물 진핵성 개시 인자5에이를 인코딩하는 디엔에이, 형질전환 식물 및식물에서의 프로그램화된 노화와 세포 사멸의 조절방법 | |
| US5861542A (en) | Gene controlling floral development and apical dominance in plants | |
| NZ502374A (en) | Production of transgenic plants in which flowering is inhibited by using the FBP10 gene | |
| WO1997025433A1 (fr) | Controle de la floraison de plantes | |
| WO1997027287A1 (fr) | Genes d'identification de meristeme floral de chou fleur et leurs procedes d'utilisation | |
| WO1997046077A1 (fr) | Plantes a semences presentant un developpement reproductif precoce et leurs procedes de production | |
| JP2004089026A (ja) | イネの開花時期および穂形態の決定に関与する新規遺伝子、そのタンパク質、及びその新規遺伝子が導入された形質転換体 | |
| AU1850100A (en) | Control of flowering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 1997930888 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2296761 Country of ref document: CA Ref country code: CA Ref document number: 2296761 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 502374 Country of ref document: NZ |
|
| NENP | Non-entry into the national phase |
Ref country code: KR |
|
| WWP | Wipo information: published in national office |
Ref document number: 1997930888 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09463147 Country of ref document: US |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1997930888 Country of ref document: EP |